Table of Contents
Conference Papers in Medicine
Volume 2013 (2013), Article ID 479352, 5 pages
http://dx.doi.org/10.1155/2013/479352
Conference Paper

Update on the Universal Definition of Acute Myocardial Infarction in the Light of New Data

1Department of Cardiology, Aarhus University Hospital, Denmark
2Department of Cardiology Campus Virchow Klinikum (CVK) and Division of Emergency Medicine CVK, CCM, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

Received 10 March 2013; Accepted 9 April 2013

Academic Editors: A. Bellou, E. Giannitsis, C. Hamm, and M. Möckel

This Conference Paper is based on a presentation given by K. Thygesen at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 K. Thygesen and J. Searle. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “EPIDEMIOLOGY of hypertension and coronary-artery disease,” British Medical Journal, vol. 2, no. 5145, p. 182, 1959.
  2. E. Rapaport, R. Bernard, and E. Corday, “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on standardization of clinical nomenclature,” Circulation, vol. 59, no. 3, pp. 607–609, 1979. View at Google Scholar · View at Scopus
  3. J. S. Alpert, E. Antman, F. Apple et al., “Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction,” European Heart Journal, vol. 21, no. 18, pp. 1502–1513, 2000. View at Google Scholar
  4. K. Thygesen, J. S. Alpert, and H. D. White, “Universal definition of myocardial infarction,” European Heart Journal, vol. 28, no. 20, pp. 2525–2538, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Third universal definition of myocardial infarction,” European Heart Journal, vol. 33, no. 20, pp. 2551–2567, 2012. View at Publisher · View at Google Scholar
  6. K. Thygesen, J. Mair, E. Giannitsis et al., “How to use high-sensitivity cardiac troponins in acute cardiac care,” European Heart Journal, vol. 33, no. 18, pp. 2252–2257, 2012. View at Google Scholar
  7. S. Mendis, K. Thygesen, K. Kuulasmaa et al., “World Health Organization definition of myocardial infarction: 2008–09 revision,” International Journal of Epidemiology, vol. 40, no. 1, pp. 139–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Jaffe, L. Babuin, and F. S. Apple, “Biomarkers in acute cardiac disease: the present and the future,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 1–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. H. B. Wu, A. S. Jaffe, F. S. Apple et al., “National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure,” Clinical Chemistry, vol. 53, no. 12, pp. 2086–2096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. F. S. Apple, L. A. Pearce, S. W. Smith, J. M. Kaczmarek, and M. M. Murakami, “Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events,” Clinical Chemistry, vol. 55, no. 5, pp. 930–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. H. B. Wu, “Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series,” Clinica Chimica Acta, vol. 401, no. 1-2, pp. 170–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. W. Macfarlane, “Age, sex, and the ST amplitude in health and disease,” Journal of Electrocardiology, vol. 34, supplement, pp. 235–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Prasad and J. Herrmann, “Myocardial infarction due to percutaneous coronary intervention,” New England Journal of Medicine, vol. 364, no. 5, pp. 453–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Yeh, S. Sidney, M. Chandra, M. Sorel, J. V. Selby, and A. S. Go, “Population trends in the incidence and outcomes of acute myocardial infarction,” New England Journal of Medicine, vol. 362, no. 23, pp. 2155–2165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. I. Parikh, P. Gona, M. G. Larson et al., “Long-term trends in myocardial infarction incidence and case fatality in the national heart, lung, and blood institute's Framingham heart study,” Circulation, vol. 119, no. 9, pp. 1203–1210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Salomaa, H. Koukkunen, M. Ketonen et al., “A new definition for myocardial infarction: what difference does it make?” European Heart Journal, vol. 26, no. 17, pp. 1719–1725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Reichlin, R. Twerenbold, M. Reiter et al., “Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis,” American Journal of Medicine, vol. 125, no. 12, pp. 1205–1213, 2012. View at Google Scholar
  18. J. Searle, O. Danne, C. Müller, and M. Mockel, “Biomarkers in acute coronary syndrome and percutaneous coronary intervention,” Minerva Cardioangiologica, vol. 59, no. 3, pp. 203–223, 2011. View at Google Scholar · View at Scopus